BrazilFrédéric Thomas leads French business of strategy consultancy CIL
International strategy consultancy CIL has hired Frédéric Thomas as partner to lead its French business.
Founded in 1986, CIL provides strategy consulting, M&A transactions and due diligence support to management teams and investors. The UK-headquartered firm has offices in the UK, the US, Germany and France – the latter launched late 2022 to serve mid-market French companies and private equity houses.
Now leading the French team is Frédéric Thomas, who has extensive experience in strategic advisory, transactions, and value creation services. He focuses on clients in the pharmaceutical and life sciences sectors. He also has industry experience in the sector, having spent seven years at Pfizer, where he managed high-performance organisational projects and business process optimisation.
Commenting on his new challenge, Thomas said: “It is an exciting time to be joining CIL. As we expand our presence in France, I’m looking forward to collaborating with the talented team here to drive growth and innovation.”
Jon Whiteman, Managing Partner at CIL, added: “I’m thrilled to welcome Frédéric to our senior team as we set the stage for CIL’s next chapter in France. His dynamic leadership and proven ability to drive growth, combined with his deep expertise in the life sciences sector, make him an invaluable addition. The opportunities ahead are vast, and I’m eager to see the progress we’ll make together in this rapidly evolving market.”
Before joining CIL, Thomas was a partner at Roland Berger, where he played a key role in enhancing large-cap coverage within the life sciences sector and in developing key accounts across Europe. He also led the Life Sciences & Health Care sector of KPMG in France for six years, driving commercial due diligence and post-deal value creation initiatives. Earlier in his career, he was a partner at Arthur D. Little.
